Thomas F Kirk bought $51k of MYO
director at MYOMO, INC.. 40,002 shares at an average of $1.27, traded Jun 5, 2026, filed Jun 9, 2026.
Score components
- +15RoleDirector
- +7Trade size$51k at market
- +3Relative to holdingsHoldings up 6%
- +8Price context57% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying4 buys in 90 days
- -5Track recordMedian 6-month excess return -49% over 7 past buys
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-263732, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | POpen-market purchase Common Stock | +40,002 | $1.27 | $51k | 693,865 | Jun 9, 2026 |
Related signals
Other insiders at MYOMO, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | MYOMO, INC. | Harry Kovelman Chief Medical Officer | $20k 15,488 shares | -15% | |
| 23Weak | MYOMO, INC. | Milton Mayo Morris director | $21k 15,000 shares | -7% | |
| 33Weak | MYOMO, INC. | Harry Kovelman Chief Medical Officer | $30k 17,500 shares | -14% | |
| 33Weak | MYOMO, INC. | Harry Kovelman Chief Medical Officer | $30k 17,250 shares | -14% | |
| 42Moderate | MYOMO, INC. | Micah Mitchell Chief Commercial Officer | $78k 90,231 shares | -45% | |
| 31Weak | MYOMO, INC. | Thomas F Kirk director | $25k 25,000 shares | +4% | |
| 33Weak | MYOMO, INC. | Harry Kovelman Chief Medical Officer | $32k 32,000 shares | -23% | |
| 42Moderate | MYOMO, INC. | Thomas F Kirk director | $68k 75,006 shares | +14% | |
| 45Moderate | MYOMO, INC. | Joseph M. Manko Jr. director | $174k 201,197 shares | +10% | |
| 34Weak | MYOsell MYOMO, INC. | Micah Mitchell Chief Commercial Officer | $78k 90,231 shares | -45% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.